GLS and neoplasm: Inhibitors of glycolysis and glutamine metabolism enzymes, such as 2-deoxyglucose (2-DG) and glutaminase inhibitors, are being investigated for their potential to disrupt tumor metabolism and inhibit tumor growth [41].